Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Gilson, Richard; Nugent, Diarmuid; Bennett, Kate; Doré, Caroline J; Murray, Macey L; Meadows, Jade; Haddow, Lewis J; Lacey, Charles; Sandmann, Frank; Jit, Mark; +5 more... Soldan, Kate; Tetlow, Michelle; Caverly, Emilia; Nathan, Mayura; Copas, Andrew J; (2020) Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. HEALTH TECHNOLOGY ASSESSMENT, 24 (47). pp. 1-86. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta24470

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta24470

Abstract

Share

Download

Filename: Gilson_etal_2020_Imiquimod_versus_podophyllotoxin_with_and.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar